Skip to content
Shuttingdown

ARTELO BIOSCIENCES, INC.

Pharmaceutical Preparations · SOLANA BEACH · CA

Distress signal

Moderate confidence (50%)

Updated Oct 19, 2026, 12:03 AM

What is happening

Derived by rule set status-rules-2026.09.7

An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

Latest material event: ARTELO BIOSCIENCES, INC. received a delisting notice from its exchange (Jan 14, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. ARTELO BIOSCIENCES, INC. received a delisting notice from its exchange

    Jan 14, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on December 31, 2025, Artelo Biosciences, Inc. (the Company ) convened and then adjourned, without conducting any business, its 2025 annual meeting of stockholders (the Annual Meeting ) due to insufficient votes to constitute a quorum. The Annual Meeting will reconvene at 8:00 a.m., Pacific Time, on Friday, January 30, 2026 to provide the Company s stockholders with additional time to vote on the proposals described in the Company s definitive proxy statement…”

Company information

Founded
—
Employees (estimate)
—
Industry
Pharmaceutical Preparations
Subindustry
—
Listing
SEC lists the ticker ARTL on Nasdaq.
SEC CIK
0001621221
Website
—
LinkedIn
—
Headquarters
SOLANA BEACH, CA
Also known as
KNIGHT KNOX DEVELOPMENT CORP., REACTIVE MEDICAL INC.
Legal entities
ARTELO BIOSCIENCES, INC.

Sources

Every material source used to build this profile.

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    ARTELO BIOSCIENCES, INC. — Pharmaceutical Preparations (SIC 2834) — SOLANA BEACH, CA
    View source record
  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on December 31, 2025, Artelo Biosciences, Inc. (the Company ) convened and then adjourned, without conducting any business, its 2025 annual meeting of stockholders (the Annual Meeting ) due to insufficient votes to constitute a quorum. The Annual Meeting will reconvene at 8:00 a.m., Pacific Time, on Friday, January 30, 2026 to provide the Company s stockholders with additional time to vote on the proposals described in the Company s definitive proxy statement…
    View source record

Status history

Every derived status, with the rule that produced it.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:32 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:15 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:32 PM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:45 PM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:59 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.